Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives.
Jean L Santos, Paulo R Yamasaki, Chung Man Chin, Célio H Takashi, Fernando R Pavan, Clarice Q F Leite
Index: Bioorg. Med. Chem. 17 , 3795-9, (2009)
Full Text: HTML
Abstract
New phthalimide derivatives were easily prepared through condensation of phthalic anhydride and selected amines with variable yields (70-90%). All compounds (3a-l) were evaluated against Mycobacterium tuberculosis H(37)Rv using Alamar Blue susceptibility. The compounds 3c, 3i, and 3l have the minimum inhibitory concentrations (MICs) of 3.9, 7.8, and 5.0 microg/mL, respectively, and could be considered new lead compounds in the treatment of tuberculosis and multi-drug resistant tuberculosis.
Related Compounds
Related Articles:
2013-01-01
[Bioorg. Med. Chem. Lett. 23(1) , 287-90, (2013)]
Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity.
2015-08-01
[Int. J. Pharm. 491 , 323-34, (2015)]
2009-01-01
[Molecules 14(8) , 2976-84, (2009)]
2014-01-01
[J. AOAC Int. 97(4) , 965-77, (2014)]
Bioanalysis and enantioseparation of dl-carnitine in human plasma by the derivatization approach.
2015-10-01
[Bioanalysis 7 , 2477-88, (2015)]